Get started
Author

Júlio Oliveira

Observed name: Julio Oliveira
Institution: IPO Porto
Observed institution: IPO Porto
ORCID: 0000-0002-9576-3486
Observed ORCID: 0000-0002-9576-3486
OpenAlex ID: A5082877309
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study
2022 · Marie Morfouace, Peter Horak, et al. · European Journal of Cancer · 14
Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al. · Clinical Cancer Research · 4
PDF
Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti–PD-1 Treatment
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al. · Cancer Immunology Research · 2
PDF
Multi-omics analysis from the IMMUcan consortium to identify predictors of chemo-immunotherapy response in early-stage triple-negative breast cancer.
2026 · Andrea Joaquin Garcia, Marcela Carausu, et al. · Journal of Clinical Oncology
Figure S5 from Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti–PD-1 Treatment
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al.
Figure S2 from Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti–PD-1 Treatment
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al.
Figure S4 from Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti–PD-1 Treatment
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al.
Data from Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti–PD-1 Treatment
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al.
Figure S3 from Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti–PD-1 Treatment
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al.
Figure S6 from Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti–PD-1 Treatment
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al.
Supplementary Tables 1-3, 5-8 from Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti–PD-1 Treatment
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al.
Figure S1 from Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti–PD-1 Treatment
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al.
Supplementary Table 4 from Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti–PD-1 Treatment
2026 · Athénaïs van der Elst, Daniel Herrero-Saboya, et al.
Works count: 13
Citation count: 20
H-index: 2
I10-index: 1
Year
Topic
Type